{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:50:53Z","timestamp":1788263453870,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Grand Program on Key Infectious Disease","award":["2012ZX10001003"],"award-info":[{"award-number":["2012ZX10001003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31271418"],"award-info":[{"award-number":["31271418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.antiviral.2013.10.010","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T14:31:02Z","timestamp":1382797862000},"page":"688-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["As2O3 synergistically reactivate latent HIV-1 by induction of NF-\u03baB"],"prefix":"10.1016","volume":"100","author":[{"given":"Pengfei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanzhang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.10.010_b0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/QAD.0b013e3282fd6df4","article-title":"Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells","volume":"22","author":"Archin","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.10.010_b0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/taap.1999.8723","article-title":"Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways","volume":"159","author":"Barchowsky","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0015","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1128\/JVI.77.5.3167-3180.2003","article-title":"As2O3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity","volume":"77","author":"Berthoux","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0360","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1128\/JVI.78.19.10507-10515.2004","article-title":"Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue","volume":"78","author":"Biancotto","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0020","doi-asserted-by":"crossref","first-page":"e2112","DOI":"10.1371\/journal.pone.0002112","article-title":"Infected cell killing by HIV-1 protease promotes NF-\u03baB dependent HIV-1 replication","volume":"3","author":"Bren","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2013.10.010_b0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature01811","article-title":"Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-\u03baB","volume":"424","author":"Brummelkamp","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.10.010_b0030","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2013.10.010_b0035","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1371\/journal.ppat.0030146","article-title":"HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K\/Akt and activates HIV transcription","volume":"3","author":"Contreras","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.10.010_b0040","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1074\/jbc.M807898200","article-title":"Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells","volume":"284","author":"Contreras","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.10.010_b0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003495-199447020-00008","article-title":"Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2013.10.010_b0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.284.5412.309","article-title":"Positive and negative regulation of I\u03baB kinase activity through IKK\u03b2 subunit phosphorylation","volume":"284","author":"Delhase","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.10.010_b0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2013.02.022","article-title":"Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation","volume":"440","author":"Ding","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.10.010_b0060","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.86.15.5974","article-title":"Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat","volume":"86","author":"Duh","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.10.010_b0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jbt.20062","article-title":"Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells","volume":"19","author":"Felix","year":"2005","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0070","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1038\/ncponc0351","article-title":"Inhibitors of DNA methylation: beyond myelodysplastic syndromes","volume":"2","author":"Fenaux","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0075","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nchembio817","article-title":"Systems biology and combination therapy in the quest for clinical efficacy","volume":"2","author":"Fitzgerald","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0080","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.86.7.2365","article-title":"Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone","volume":"86","author":"Folks","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.10.010_b0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-199204000-00001","article-title":"Cellular transcription factors involved in the regulation of HIV-1 gene expression","volume":"6","author":"Gaynor","year":"1992","journal-title":"AIDS"},{"issue":"Suppl.","key":"10.1016\/j.antiviral.2013.10.010_b0090","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2013.10.010_b0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.onc.1206111","article-title":"P53-associated 3\u2032\u21925\u2032 exonuclease activity in nuclear and cytoplasmic compartments of cells","volume":"22","author":"Gila","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2013.10.010_b0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/339070a0","article-title":"Activation of HIV gene expression during monocyte differentiation by induction of NF-\u03baB","volume":"339","author":"Griffin","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.10.010_b0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-4274(02)00083-8","article-title":"Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression","volume":"133","author":"Hu","year":"2002","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.antiviral.2013.10.010_b0110","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1639","article-title":"Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes","volume":"13","author":"Huang","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2013.10.010_b0115","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1074\/jbc.M110.103531","article-title":"Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294","volume":"285","author":"Imai","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.10.010_b0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(99)00282-7","article-title":"Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid \u03b2-protein and chloroquine in cultured rat astrocytes","volume":"266","author":"Isobe","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.antiviral.2013.10.010_b0120","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2013.10.010_b0125","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/smim.2000.0210","article-title":"The I\u03baB kinase (IKK) and NF-\u03baB: key elements of proinflammatory signalling","volume":"12","author":"Karin","year":"2000","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/COH.0b013e328340ffbb","article-title":"The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit","volume":"6","author":"Karn","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.antiviral.2013.10.010_b0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1074-7613(00)80326-X","article-title":"The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells","volume":"6","author":"Kinoshita","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2013.10.010_b0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cyto.2003.11.007","article-title":"Aspirin inhibits TNF\u03b1- and IL-1-induced NF-\u03baB activation and sensitizes HeLa cells to apoptosis","volume":"25","author":"Kutuk","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.antiviral.2013.10.010_b0150","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1371\/journal.ppat.0020068","article-title":"Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells","volume":"2","author":"Lassen","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.10.010_b0155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","article-title":"Depletion of latent HIV-1 infection in vivo: a proof-of-concept study","volume":"366","author":"Lehrman","year":"2005","journal-title":"The Lancet"},{"key":"10.1016\/j.antiviral.2013.10.010_b0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/nar\/gks976","article-title":"The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation","volume":"41","author":"Li","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2013.10.010_b0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.chom.2013.05.006","article-title":"Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells","volume":"13","author":"Lusic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2013.10.010_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/dkn455","article-title":"Eradication of HIV: current challenges and new directions","volume":"63","author":"Marsden","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.10.010_b0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2174\/157016211798998736","article-title":"Control of HIV latency by epigenetic and non-epigenetic mechanisms","volume":"9","author":"Mbonye","year":"2011","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.antiviral.2013.10.010_b0180","doi-asserted-by":"crossref","first-page":"e11160","DOI":"10.1371\/journal.pone.0011160","article-title":"Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner","volume":"5","author":"Mehla","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.10.010_b0185","first-page":"3893","article-title":"Mechanisms of action of arsenic trioxide","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2013.10.010_b0190","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/326711a0","article-title":"An inducible transcription factor activates expression of human immunodeficiency virus in T cells","volume":"326","author":"Nabel","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.10.010_b0195","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.molcel.2009.06.003","article-title":"Cellular microRNA and P bodies modulate host-HIV-1 interactions","volume":"34","author":"Nathans","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2013.10.010_b0200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.virol.2010.12.041","article-title":"HIV reservoirs and latency models","volume":"411","author":"Pace","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.10.010_b0205","doi-asserted-by":"crossref","first-page":"21096","DOI":"10.1074\/jbc.272.34.21096","article-title":"Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo","volume":"272","author":"Pierce","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.10.010_b0210","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.1128\/JVI.00800-07","article-title":"Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells","volume":"81","author":"Pion","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0215","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00002030-199912030-00012","article-title":"Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy","volume":"13","author":"Prins","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.10.010_b0220","doi-asserted-by":"crossref","first-page":"e32215","DOI":"10.1371\/journal.pone.0032215","article-title":"Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6","volume":"7","author":"Qu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.10.010_b0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2012.05.003","article-title":"The development of immune-modulating compounds to disrupt HIV latency","volume":"23","author":"Remoli","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.antiviral.2013.10.010_b0230","doi-asserted-by":"crossref","first-page":"e6093","DOI":"10.1371\/journal.pone.0006093","article-title":"Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection","volume":"4","author":"Reuse","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.10.010_b0235","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection","volume":"323","author":"Richman","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.10.010_b0240","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/abbi.2000.1770","article-title":"Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation","volume":"377","author":"Roussel","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.antiviral.2013.10.010_b0245","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/QAD.0b013e3282fd6ddc","article-title":"Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir","volume":"22","author":"Sagot-Lerolle","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.10.010_b0250","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/JVI.80.4.2051-2054.2006","article-title":"Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner","volume":"80","author":"Sebastian","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0255","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2013.10.010_b0260","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/abbi.1997.0470","article-title":"Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism","volume":"349","author":"Shumilla","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.antiviral.2013.10.010_b0265","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/511823","article-title":"Stability of the latent reservoir for HIV-1 in patients receiving valproic acid","volume":"195","author":"Siliciano","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.10.010_b0270","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.10.010_b0275","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1189\/jlb.0310176","article-title":"Arsenic modulates APOBEC3G-mediated restriction to HIV-1 infection in myeloid dendritic cells","volume":"88","author":"Stalder","year":"2010","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0280","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.taap.2010.02.012","article-title":"Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells","volume":"244","author":"Sumi","year":"2010","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.antiviral.2013.10.010_b0285","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nbt.2391","article-title":"Systematic identification of synergistic drug pairs targeting HIV","volume":"30","author":"Tan","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1039\/a809656b","article-title":"A water-soluble tetrazolium salt useful for colorimetric cell viability assay","volume":"36","author":"Tominaga","year":"1999","journal-title":"Anal. Commun."},{"key":"10.1016\/j.antiviral.2013.10.010_b0290","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2119\/molmed.2012.00194","article-title":"HIV latency: the major hurdle in HIV eradication","volume":"18","author":"Tyagi","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.antiviral.2013.10.010_b0295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/aid.2011.0263","article-title":"Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy","volume":"28","author":"Victoriano","year":"2012","journal-title":"AIDS Res. Hum. Retrov."},{"key":"10.1016\/j.antiviral.2013.10.010_b0300","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1099\/0022-1317-74-11-2401","article-title":"Hexamethylene bisacetamide activates the human immunodeficiency virus type 1 provirus by an NF-\u03baB-independent mechanism","volume":"74","author":"Vlach","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1172\/JCI200522574","article-title":"IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART","volume":"115","author":"Wang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2013.10.010_b0310","doi-asserted-by":"crossref","first-page":"42008","DOI":"10.1074\/jbc.M402124200","article-title":"Prostratin antagonizes HIV latency by activating NF-\u03baB","volume":"279","author":"Williams","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.10.010_b0315","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1128\/JVI.00523-10","article-title":"Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction","volume":"84","author":"Wolschendorf","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0320","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jac\/dkr496","article-title":"Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation","volume":"67","author":"Xing","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.10.010_b0325","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1128\/JVI.02033-10","article-title":"Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation","volume":"85","author":"Xing","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.010_b0330","first-page":"1","article-title":"Targeting HIV latency: pharmacologic strategies toward eradication","volume":"00","author":"Xing","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2013.10.010_b0335","first-page":"3473","article-title":"Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation","volume":"119","author":"Yang","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2013.10.010_b0340","doi-asserted-by":"crossref","first-page":"e48832","DOI":"10.1371\/journal.pone.0048832","article-title":"Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB","volume":"7","author":"Ying","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2013.10.010_b0345","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00002030-200405210-00003","article-title":"Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression","volume":"18","author":"Ylisastigui","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.10.010_b0350","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/MMBR.00011-06","article-title":"The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation","volume":"70","author":"Zhou","year":"2006","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.antiviral.2013.10.010_b0355","first-page":"697","article-title":"Abnormal nuclear factor (NF)-\u03baB signal pathway and aspirin inhibits tumor necrosis factor \u03b1- induced NF-\u03baB activation in Keloid fibroblasts","volume":"33","author":"Zhu","year":"2007","journal-title":"Dermatol. Surg."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T20:54:45Z","timestamp":1596747285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213003008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0166354213003008"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.10.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"As2O3 synergistically reactivate latent HIV-1 by induction of NF-\u03baB","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}